Tenon Medical

Tenon Medical Forward P/E

The Forward P/E Ratio of Tenon Medical (TNON) as of Oct 21, 2026 is -0.65. In the previous year, Forward P/E Ratio was -0.60 — a change of 8.90% (lower).

Forward P/E

-0.65

YoY

8.90%

Last updated:

Forward P/E Ratio of Tenon Medical is 2025 -0.65 . Forward P/E Ratio of Tenon Medical was 2024 -0.60 . It decreases by 8.90% lower compared to the previous year.

The Tenon Medical Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2019
-16.10 USD
Jan 1, 2020
-14.02 USD
Jan 1, 2021
-1.16 USD
Jan 1, 2022
-0.43 USD
Jan 1, 2023
-0.53 USD
Jan 1, 2024
-0.60 USD
Jan 1, 2025
-0.65 USD
The Tenon Medical Forward P/E history
YEARForward P/EYoY
-0.65+8.90%
-0.60+13.95%
-0.53+21.41%
-0.43-62.74%
-1.16-91.70%
-14.02-12.92%
-16.10—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tenon Medical Stock analysis

What does Tenon Medical do? Tenon Medical Inc generates revenue through the sale of its Catamaran SI Joint Fusion System, a medical device designed to treat sacroiliac joint disorders causing lower back pain. The system includes the Catamaran Fixation Device, which stabilizes the SI Joint by transfixing it along its longitudinal axis using a single titanium implant. The company targets orthopedic surgeons and hospitals specializing in spinal and joint treatments, with the Catamaran System marketed as a solution for the most common SI Joint disorders. Tenon Technology AG serves as the company's subsidiary, supporting the development and commercialization of the medical device technology. The Catamaran System is positioned as a specialized surgical solution, featuring a unique approach that avoids critical neural and vascular structures while targeting strong cortical bone. The company's focus on the sacroiliac joint market differentiates it from broader orthopedic device manufacturers, with the product designed to address specific patient needs in lower back pain management. Revenue streams are derived from direct sales of the system to healthcare providers and hospitals, leveraging the proprietary surgical technique and implant design. Tenon Medical Inc. operates within the Health Care Equipment & Supplies industry, with its primary product being the Catamaran SI Joint Fusion System. The company's business model centers on developing and selling medical devices that provide targeted treatment for SI Joint disorders, using a single titanium implant that transfixes the joint. The subsidiary Tenon Technology AG plays a role in supporting the company's technological advancements and market positioning. Tenon Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tenon Medical stock

Forward P/E Ratio of Tenon Medical is -0.65 in 2025.

Forward P/E Ratio of Tenon Medical changed from -0.60 to -0.65, representing a 8.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Tenon Medical since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Tenon Medical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Tenon Medical

All Key Metrics — Tenon Medical